The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system
Open accessAbstract
Macrolide-resistant Streptococcus pyogenes isolates from Finland, Australia, and the United Kingdom and, more recently, Streptococcus pneumoniae and S. pyogenes strains from the United States were shown to have an unusual resistance pattern to macrolides, lincosamides, and streptogramin B antibiotics. This pattern, referred to as M resistance, consists of susceptibility to clindamycin and streptogramin B antibiotics but resistance to 14- and 15-membered macrolides. An evaluation of the macrolide-lincosamide-streptogramin B resistance phenotypes among our streptococcal strains collected from 1993 to 1995 suggested that this unusual resistance pattern is not rare. Eighty-five percent (n = 66) of the S. pneumoniae and 75% (n = 28) of the S. pyogenes strains in our collection had an M phenotype. The mechanism of M resistance was not mediated by target modification, as isolated ribosomes from a pneumococcal strain bearing the M phenotype were fully sensitive to erythromycin. Further, the presence of an erm methylase was excluded with primers specific for an erm consensus sequence. However, results of studies that determined the uptake and incorporation of radiolabeled erythromycin into cells were consistent with the presence of a macrolide efflux determinant. The putative efflux determinant in streptococci seems to be distinct from the multicomponent macrolide efflux system in coagulase-negative staphylococci. The recognition of the prevalence of the M phenotype in streptococci has implications for sensitivity testing and may have an impact on the choice of antibiotic therapy in clinical practice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
National Committee for Clinical Laboratory Standards
Bruck, E. (1980) · Pediatrics · doi:10.1542/peds.65.1.187 · Cited by 14,751
STUDIES ON THE CHEMICAL NATURE OF THE SUBSTANCE INDUCING TRANSFORMATION OF PNEUMOCOCCAL TYPES
Avery, O. T., MacLeod, C. M., & McCarty, M. (1944) · Journal of Experimental Medicine · doi:10.1084/jem.79.2.137 · Cited by 2,683
Prevention of Drug Access to Bacterial Targets: Permeability Barriers and Active Efflux
Nikaido, H. (1994) · Science · doi:10.1126/science.8153625 · Cited by 1,540
The toxic shock syndrome exotoxin structural gene is not detectably transmitted by a prophage
Kreiswirth, B. N., Löfdahl, S., Betley, M. J., O'Reilly, M., Schlievert, P. M., Bergdoll, M. S., & Novick, R. P. (1983) · Nature · doi:10.1038/305709a0 · Cited by 1,326
Erythromycin resistance by ribosome modification
Weisblum, B. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.3.577 · Cited by 1,008
Detection of erythromycin-resistant determinants by PCR
Sutcliffe, J., Grebe, T., Tait-Kamradt, A., & Wondrack, L. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.11.2562 · Cited by 989
Self-citationAvery, O. T., MacLeod, C. M., & McCarty, M. (2017) · Klassische Texte der Wissenschaft · doi:10.1007/978-3-662-47150-0_2 · Cited by 756
Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification
Leclercq, R., & Courvalin, P. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.7.1267 · Cited by 628
Emergence of Drug-Resistant Pneumococcal Infections in the United States
Breiman, R. F. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03510470035031 · Cited by 562
Hagman, K. E., Spratt, B. G., Balthazar, J. T., Pan, W., Judd, R. C., & Shafer, W. M. (1995) · Microbiology · doi:10.1099/13500872-141-3-611 · Cited by 368
Ross, J. I., Eady, E. A., Cove, J. H., Cunliffe, W. J., Baumberg, S., & Wootton, J. C. (1990) · Molecular Microbiology · doi:10.1111/j.1365-2958.1990.tb00696.x · Cited by 358
Resistance to Erythromycin in Group A Streptococci
Seppälä, H., Nissinen, A., Järvinen, H., Huovinen, S., Henriksson, T., Herva, E., Holm, S. E., Jahkola, M., Katila, M.-L., Klaukka, T., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201303260503 · Cited by 350
Multidrug resistance pumps in bacteria: variations on a theme
Lewis, K. (1994) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(94)90204-6 · Cited by 306
Three different phenotypes of erythromycin-resistant Streptococcus pyogenes in Finland
Seppälä, H., Nissinen, A. E. T., Yu, Q., & Huovinen, P. (1993) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/32.6.885 · Cited by 297
Nikaido, H., & Thanassi, D. G. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.7.1393 · Cited by 280
Altered Methylation of Ribosomal RNA in an Erythromycin-Resistant Strain of Staphylococcus aureus
Lai, C. J., & Weisblum, B. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.4.856 · Cited by 274
Insights into erythromycin action from studies of its activity as inducer of resistance
Weisblum, B. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.4.797 · Cited by 267
Binding protein-dependent transport systems
Higgins, C. F., Hyde, S. C., Mimmack, M. M., Gileadi, U., Gill, D. R., & Gallagher, M. P. (1990) · Journal of Bioenergetics and Biomembranes · doi:10.1007/bf00762962 · Cited by 264
Antimicrobial Resistance of Streptococcus pneumoniae in the United States, 1979-1987
Spika, J. S., Facklam, R. R., Plikaytis, B. D., Oxtoby, M. J., & Pneumococcal Surveillance Working Group (1991) · Journal of Infectious Diseases · doi:10.1093/infdis/163.6.1273 · Cited by 261
Leclercq, R., & Courvalin, P. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.7.1273 · Cited by 230
Triple post‐transcriptional control
Bechhofer, D. H. (1990) · Molecular Microbiology · doi:10.1111/j.1365-2958.1990.tb02051.x · Cited by 204
Weisblum, B. (1985) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/16.suppl_a.63 · Cited by 196
Meier, A., Kirschner, P., Springer, B., Steingrube, V. A., Brown, B. A., Wallace, R. J., & Böttger, E. C. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.2.381 · Cited by 195
Dubnau, D., & Nomura, M. (1984) · Critical Reviews in Biochemistry · doi:10.3109/10409238409102300 · Cited by 179
Clinical strain of Staphylococcus aureus inactivates and causes efflux of macrolides
Wondrack, L. M., Massa, M. A., Yang, B. V., & Sutcliffe, J. A. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.4.992 · Cited by 162
Self-citationRegulation of the permeability of the gonococcal cell envelope by the mtr system
Pan, W., & Spratt, B. G. (1994) · Molecular Microbiology · doi:10.1111/j.1365-2958.1994.tb00354.x · Cited by 155
Dilemmas in diagnosis and management of cephalosporin-resistant Streptococcus pneumoniae meningitis
Friedland, I. R., Shelton, S., Paris, M. M., Rinderknecht, S. B., Ehrett, S., Krisher, K., & McCracken, G. H. (1993) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199303000-00004 · Cited by 151
Fernández-Muñoz, R., Monro, R. E., Vázquez, D., & Torres‐Pinedo, R. (1971) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1971.tb01607.x · Cited by 145
Arthur, M., Andremont, A., & Courvalin, P. M. (1987) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.31.3.404 · Cited by 118
Ross, J. I., Farrell, A. M., Eady, E. A., Cove, J. H., & Cunliffe, W. J. (1989) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/24.6.851 · Cited by 118
Enzymic hydrolysis of erythromycin by a strain of Escherichia coli. A new mechanism of resistance.
BARTHÉLÉMY, P., AUTISSIER, D., Gerbaud, G., & Courvalin, P. M. (1984) · The Journal of Antibiotics · doi:10.7164/antibiotics.37.1692 · Cited by 118
O'Hara, K., Kanda, T., Ohmiya, K., Ebisu, T., & Kono, M. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.8.1354 · Cited by 114
Noguchi, N., EMURA, A., Matsuyama, H., O'Hara, K., Sasatsu, M., & Kono, M. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.10.2359 · Cited by 105
Erythromycin series. Part 11. Ring expansion of erythromycin A oxime by the Beckmann rearrangement
Djokić, S., Kobrehel, G., Lazarevski, G., Lopotar, N., Tamburašev, Z., Kamenar, B., Nagl, A., & Vickovic, I. (1986) · Journal of the Chemical Society Perkin Transactions 1 · doi:10.1039/p19860001881 · Cited by 103
Brisson-Noël, A., Delrieu, P., Samain, D., & Courvalin, P. M. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)37532-x · Cited by 98
Nucleotide sequence of the gene ereA encoding the erythromycin esterase in Escherichia coli
Ounissi, H., & Courvalin, P. M. (1985) · Gene · doi:10.1016/0378-1119(85)90005-8 · Cited by 96
Analysis of the nucleotide sequence of theereBgene encoding the erythromydn esterase type II
Arthur, M., AUTISSIER, D., & Courvalin, P. M. (1986) · Nucleic Acids Research · doi:10.1093/nar/14.12.4987 · Cited by 85
Arthur, M., Molinas, C., Mabilat, C., & Courvalin, P. M. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.10.2024 · Cited by 81
Ross, J. I., Eady, E. A., Cove, J. H., & Baumberg, S. (1995) · Gene · doi:10.1016/0378-1119(94)00833-e · Cited by 79
The emergence of erythromycin resistance in Streptococcus pyogenes in Fremantle, Western Australia
Stingemore, N., Francis, G. R. J., Toohey, M., & McGechie, D. B. (1989) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1989.tb136725.x · Cited by 63
Erythromycin-resistant Streptococcus pyogenes
Phillips, G., Parratt, D., Orange, G., Harper, I., McEWAN, H., & Young, N. J. (1990) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/25.4.723 · Cited by 60
Phenotypic expression and genetic heterogeneity of lincosamide inactivation in Staphylococcus spp
Leclercq, R., Brisson-Noël, A., Duval, J., & Courvalin, P. M. (1987) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.31.12.1887 · Cited by 55
Kono, M., Ohara, K., & Ebisu, T. (1992) · FEMS Microbiology Letters · doi:10.1016/0378-1097(92)90369-y · Cited by 46
Milton, I. D. (1992) · FEMS Microbiology Letters · doi:10.1016/0378-1097(92)90377-z · Cited by 39
Pernodet, J., Boccard, F., Alegre, M. T., et al. (1988) · The EMBO Journal · doi:10.1002/j.1460-2075.1988.tb02810.x · Cited by 38
Lampson, B. C., von David, W., & Parisi, J. T. (1986) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.30.5.653 · Cited by 38
Plasmid mediated pristinamycin resistance: PH 1A, a pristinamycin 1A hydrolase.
Goffic, F. L., Capmau, M.-L., Abbe, J., Cerceau, C., Dublanchet, A., & Duval, J. (1977) · PubMed · Cited by 36
Jánosi, L., Nakajima, Y., & Hashimoto, H. (1990) · Microbiology and Immunology · doi:10.1111/j.1348-0421.1990.tb01050.x · Cited by 20
Cited by
Detection of erythromycin-resistant determinants by PCR
Sutcliffe, J., Grebe, T., Tait-Kamradt, A., & Wondrack, L. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.11.2562 · Cited by 989
Self-citationNomenclature for Macrolide and Macrolide-Lincosamide-Streptogramin B Resistance Determinants
Roberts, M. C., Sutcliffe, J., Courvalin, P., Jensen, L. B., Rood, J., & Seppala, H. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.12.2823 · Cited by 874
Self-citationEfflux-Mediated Drug Resistance in Bacteria
Li, X.-Z., & Nikaido, H. (2004) · Drugs · doi:10.2165/00003495-200464020-00004 · Cited by 798
Natural Products as Platforms To Overcome Antibiotic Resistance
Rossiter, S. E., Fletcher, M. H., & Wuest, W. M. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00283 · Cited by 622
Heffelfinger, J. D. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.10.1399 · Cited by 610
Metadata
- Authors
- Sutcliffe, J., Tait-Kamradt, A., & Wondrack, L.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 1996-08
- Volume
- 40
- Issue
- 8
- Pages
- 1817-1824
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2127686385
- Cited by
- 619
- References
- 48
- FWCI
- 20.80
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.